EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“How can we better capture what matters most to cancer patients?
The SISAQOL-IMI consortium sets global standards for analysing patient-reported outcomes and quality of life in cancer clinical trials—to be published soon.
For more information about the consortium, watch the video below.
Read more about the recommendations developed by the consortium on the SISAQOL-IMI website.”
More posts featuring EORTC.